Activation of the orphan nuclear receptor RORα induces growth arrest in androgen-independent DU 145, prostate cancer cells

Prostate

Volumn 46, Issue 4, 2001, Pages 327-335

  Moretti, Roberta M ^a   Marelli, Marina Montagnani ^a   Motta, Marcella ^a   Polizzi, Donatella ^b   Monestiroli, Silvia ^b   Pratesi, Graziella ^b   Limonta, Patrizia ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Cell cycle related genes; Cell proliferation; Orphan nuclear receptors; Prostate cancer

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANDROGEN; CELL NUCLEUS RECEPTOR; CYCLIN A; PROTEIN P21;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; CANCER CELL; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIGANDS; MALE; MICE; MICE, NUDE; PROSTATIC NEOPLASMS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THIAZOLES; THIOSEMICARBAZONES; TRANS-ACTIVATORS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0035283192     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0045(20010301)46:4<327::AID-PROS1040>3.0.CO;2-6     Document Type: Article

References (36)

1. Cancer statistics 1997
2. Molecular genetics and epidemiology of prostate cancer
3. Maximal androgen withdrawal for prostate cancer therapy: Current status and future potential
4. Current chemotherapy and future directions in research for the treatment of advanced hormone-refractory prostate cancer
5. Identification of nuclear receptor mRNAs by RT-PCR amplification of conserved zinc-finger motif sequences
6. RZRs, a novel class of retinoid related orphan receptors that function as both monomers and homodimers
7. Isoform-specific amino-terminal domains dictate DNA-binding properties of RORα a novel family of orphan homone nuclear receptors
8. Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily
9. RORγ: The third member of ROR/RZR orphan receptor subfamily that is highly expressed in skeletal muscle
10. Staggerer phenotype in retinoid-related orphan receptor α-deficient mice
11. Transcriptional regulation of apolipoprotein A-I gene expression by the nuclear receptor RORα
12. Identification of natural monomeric response elements of the nuclear receptor RZR/ROR: They also bind COUP-TF
13. - cells
14. Thiazolidine diones, specific ligands of the nuclear receptor retinoid Z receptor/retinoid acid receptor-related orphan receptor α with potent antiarthritic activity
15. Specific activation of the nuclear receptors PPARγ and RORA by the antidiabetic thiazolidinedione BRL 49653 and the antiarthritic thiazolidinedione derivative CGP 52608
16. Differential regulation of the N-myc proto-oncogene by RORα and RVR, two orphan members of the superfamily of nuclear hormone receptors
17. Expression and amplification of the N-myc gene in primary retinoblastoma
18. Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma
19. Human small-cell lung cancers show amplification and expression of the N-myc gene
20. Antiproliferative effects of melatonin and CGP 52608 on the murine colon 38 adenocarcinoma in vitro and in vivo
21. Are nuclear receptors involved in pituitary responsiveness to melatonin?
22. In vivo enhanced antitumor activity of carmustine [N,N′-bis(2-chloroethyl)-N-nitrosurea] by simvastatin
23. WAF1, a potential mediator of p53 tumor suppression
24. Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma
25. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA
26. United Kingdom co-ordinating committee on cancer research (UKCCCR) guidelines for the welfare of animals in experimental neoplasia (second edition)
27. A multiple comparison procedure for comparing several treatments with a control
28. G1 phase progression: Cycling on cue
29. Structure and cell cycle-regulated transcription of the human cyclin A gene
30. The potential role of the transcription factor RZR/ROR as a mediator of nuclear melatonin signaling
31. RORα augments thyroid hormone receptor-mediated transcriptional activation
32. Recombinant humanized anti-HER2 antibody (Herceptin™) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts
33. The metastasis suppressor candidate nucleotide diphosphate kinase NM23 specifically interacts with members of the ROR/RZR nuclear orphan receptor subfamily
34. Transcriptional activation of the nuclear receptor RZRα by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand